4.6 Article

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

R. Berardi et al.

Summary: During the COVID-19 pandemic in Italy, healthcare professionals are facing social distress, including concerns about infecting their families and lack of personal protective equipment. These worries were significantly associated with insufficient PPE supply, screening procedures, and training. A majority of respondents reported changes in family organization, which was significantly correlated with the fear of infecting their relatives.

ESMO OPEN (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, Research & Experimental

Assessing the impact of COVID-19 on registered interventional clinical trials

Nour Hawila et al.

Summary: The study found that COVID-19 had minimal impact on the number of submitted clinical trials, but a more substantial impact on completed trials. Clinical trials sponsored by pharmaceutical companies were more successful at completion during the pandemic compared to those sponsored by academic/hospital/government entities.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Review Oncology

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Rachel Riera et al.

Summary: The study identified a high frequency of delays and disruptions in cancer care services globally due to the reduction in service availability caused by the COVID-19 pandemic. Various categories of delays and disruptions were found to impact cancer treatment, diagnosis, and general health services.

JCO GLOBAL ONCOLOGY (2021)

Article Oncology

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Masumi Ueda et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Editorial Material Oncology

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment

Avinash G. Dinmohamed et al.

LANCET ONCOLOGY (2020)

Article Oncology

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

Elizabeth Lerner Papautsky et al.

BREAST CANCER RESEARCH AND TREATMENT (2020)

Editorial Material Multidisciplinary Sciences

COVID-19 and cancer

Norman E. Sharpless

SCIENCE (2020)

Article Medicine, General & Internal

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers

Eugene B. Cone et al.

JAMA NETWORK OPEN (2020)

Article Oncology

Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

Jack W. London et al.

JCO CLINICAL CANCER INFORMATICS (2020)